Title: Innovations by Chenying Guo in Glaucoma Treatment Introduction Chenying Guo is an accomplished inventor based in Malden, MA (US). He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. With a total of 2 patents, his work focuses on promoting neuronal growth to combat optic nerve degeneration. Latest Patents Chenying Guo's latest patents include innovative methods aimed at reducing the severity of glaucoma. One of his patents, titled "Methods of reducing severity of glaucoma by intravitreal administration of insulin-like growth factor binding protein-like 1 (IGFBPL1)," discloses a method of promoting neuronal growth by administering IGFBPL-1 or an agent that increases or stabilizes IGFBPL-1 activity to a subject in need. This method is particularly beneficial for treating optic nerve degeneration. Another patent, "Methods for promoting neuronal outgrowth by insulin-like growth factor binding protein-like 1 (IGFBPL-1) in glaucoma or Leber's optic neuropathy," also focuses on promoting neuronal growth through similar mechanisms. Career Highlights Chenying Guo is currently affiliated with The Schepens Eye Research Institute, Inc., where he continues to advance research in eye health and treatment methodologies. His work has garnered attention for its potential to improve outcomes for patients suffering from glaucoma and related conditions. Collaborations Chenying Guo collaborates with esteemed colleagues in his field, including Dong Feng Chen, to further enhance the impact of his research and innovations. Conclusion Chenying Guo's contributions to glaucoma treatment through his innovative patents highlight the importance of research in advancing medical science. His work not only addresses critical health issues but also paves the way for future developments in ophthalmology.

Growing community of inventors

Malden, MA, United States of America

Chenying Guo